// App-Quantinova.ai

: Targeted exhaled breath analysis for detection of Pseudomonas aeruginosa in cystic fibrosis patients

Researchers

Presenter

  • Renate Kos

Principal Investigators

  • Paul Brinkman

  • Anne H Neerincx

  • Tamara Paff

  • Marije G Gerritsen

  • Ariane Lammers

  • Aletta D Kraneveld

  • Harry G M Heijerman

  • Jane C Davies

  • Hettie M Janssens

  • Christof J Majoor

  • Els J Weersink

  • Peter J Sterk

  • Eric G Haarman

  • Lieuwe Bos

  • Anke H Maitland-Van Der Zee

Medical Centers

  • Department of Respiratory Medicine, Amsterdam University Medical Centers (Amsterdam UMC), University of Amsterdam, Amsterdam, Netherlands

  • Department of Pediatric Respiratory Medicine and Allergy,Emma Childrens Hospital/Academic Medical Center, Amsterdam, Netherlands

  • Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht, Netherlands

  • Department of Respiratory Medicine, University Medical Centre Utrecht, Utrecht, Netherlands,

  • National Heart and Lung Institute, Imperial College London, London, United Kingdom

  • Department of Pediatrics, div. of Respiratory medicine and Allergology, ErasmusMC Sophia Children's Hospital, University Hospital Rotterdam, Rotterdam, Netherlands

Locations

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cystic Fibrosis

Biomarkers

  • Volatile organic compounds

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A